[Federal Register Volume 79, Number 67 (Tuesday, April 8, 2014)]
[Notices]
[Page 19339]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-07776]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Surveillance and Research of 
Muscular Dystrophies and Neuromuscular Disorders, FOA DD14-001, initial 
review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Times and Dates:
9:00 a.m.-6:00 p.m., April 22, 2014 (Closed)
9:00 a.m.-6:00 p.m., April 23, 2014 (Closed)
9:00 a.m.-6:00 p.m., April 24, 2014 (Closed)
    Place: Teleconference
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters For Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Surveillance and Research of Muscular Dystrophies and 
Neuromuscular Disorders, FOA DD14-001, initial review.''
    Contact Person For More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80, 
Atlanta, Georgia 30341, Telephone: (770) 488-3585, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-07776 Filed 4-7-14; 8:45 am]
BILLING CODE 4163-18-P